{"url_path":"/sec/hca/8-k/2026-06-18/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-18","source_url":"https://www.sec.gov/Archives/edgar/data/860730/0001193125-26-275086-index.html","accession_number":"0001193125-26-275086","cik":"0000860730","ticker":"HCA","issuer_name":"HCA Healthcare, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/860730/0001193125-26-275086-index.html","primary_entity_key":"0000860730","primary_entity_name":"HCA Healthcare, Inc."},"word_count":139,"has_tables":true,"body_markdown":"Item 5.02.\n\nDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n\nOn June 15, 2026, Dr. Michael Cuffe and HCA Healthcare, Inc. (the “Company”) agreed that Dr. Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and thereafter continue in a transitional role with the Company until February 2027. Dr. Cuffe will be eligible to receive benefits according to the Company’s executive severance policy and applicable incentive plans.\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nHCA HEALTHCARE, INC.\n\nBy:\n \n\n/s/ John M. Franck II\n\n \nJohn M. Franck II\n\n \nVice President – Legal and Corporate Secretary\n\nDate: June 18, 2026"}